Rituxan (rituximab) - Roche
bendamustine - Generic mfg.
Isolated Kidney Involvement as the Initial Manifestation of Recurrent Mantle-Cell Lymphoma (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO1256; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "He was treated with corticosteroids, Bendamustine (Alkylating agent), and rituximab (B-cell depleting agent) therapy targeting the mantle cell lymphoma with marked improvement of his creatinine back to baseline and resolution of his proteinuria. Patients presenting with acute kidney injury with history of mantle cell lymphoma should have low threshold for biopsy. Early detection and management can prevent progressive kidney disease." 
Acute Kidney Injury • B Cell Non-Hodgkin Lymphoma • Glomerulonephritis • Hematological Malignancies • Immunology • Lupus Nephritis • Lymphoma • Mantle Cell Lymphoma • Nephrology • Non-Hodgkin's Lymphoma • Renal Disease
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4558900
 
Christian J. Wiscombe; Koyal Jain; Manish K. Saha
 
Oct 2, 2026
 
Prev Next